Practical aspects of using botulinum toxin type B

European Journal of Neurology

Volumn 8, Issue SUPPL. 4, 2001, Pages 19-21

  Barnes, M P ^a  

^a Hunters Moor Regional Rehabilitation Centre   (United Kingdom)

Author keywords

Botulinum toxin type b; Cervical dystonia

Indexed keywords

EID: 0842316231     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Arezzo JC, Litwak MS, Caputo FA et al. (2000). A comparison of the spread of biological activity of NeuroBloc™ (botulinum toxin type B) and Botox (botulinum toxin type A) in a monkey model. Mov Disord 15(Suppl. 3):159.
2. Brashear A, Lew MF, Dykstra DD et al. (1999). Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 53:1439-1446.
3. Brin MF, Lew MF, Adler CH et al. (1999). Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 53:1431-1438.
4. Odergren T, Hjaltason H, Kaakkola S et al. (1998). A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neural Neurosurg Psychiatry 64:6-12.